Nina Niu Sanford/utswmed.org
May 29, 2025, 22:58
Nina Niu Sanford: A good primer on complexities of measuring QOL in cancer clinical trials
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post by Massimo Di Maio, Associate Professor of Medical Oncology at Department of Oncology, University of Turin, adding:
“A good primer on complexities of measuring QOL in cancer clinical trials. TLDR: QOL = important pt-centered outcome…but accurately and reproducibly comparing QOL b/w regimens challenging, pros/cons of dif analyses, and currently no standard methodology.
Worth a pre-ASCO25 read.”
Quoring Massimo Di Maio‘s post:
“Have a look at my review seeking to help clinicians gain familiarity with the correct reading and interpretation of QoL results in cancer clinical trials, just published in NEJM Evidence.”
Title: Reading and Interpreting Quality-of-Life Results in Cancer Trials
Author: Massimo Di Maio
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 7, 2025, 17:41
Jun 7, 2025, 16:47
Jun 7, 2025, 16:40
Jun 7, 2025, 16:30
Jun 7, 2025, 16:07
Jun 7, 2025, 15:49